Curtis; Neil Roy
Patent Applications and Registrations
Patent applications and USPTO patent grants for Curtis; Neil Roy.The latest application filed is for "arylsulfonyl benzofused heterocycles as 5-ht2a antagonists".
- Curtis; Neil Roy - Buntingford GB
- Curtis; Neil Roy - Puckeridge GB
| Patent | Date |
|---|---|
| Arylsulfonylnaphthalene derivatives as 5HT.sub.2A antagonists Grant 7,592,456 - Chambers , et al. September 22, 2 | 2009-09-22 |
| Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists App 20090012134 - Curtis; Neil Roy ; et al. | 2009-01-08 |
| Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists App 20070281952 - Chambers; Mark Stuart ; et al. | 2007-12-06 |
| 5-HT.sub.7 receptor antagonists Grant 7,276,607 - Curtis , et al. October 2, 2 | 2007-10-02 |
| 5-HT.sub.2A receptor ligands Grant 7,094,777 - Chambers , et al. August 22, 2 | 2006-08-22 |
| Novel 5-HT2A receptor ligands App 20050101586 - Chambers, Mark Stuart ; et al. | 2005-05-12 |
| 5-ht7 receptor antagonists App 20050080077 - Curtis, Neil Roy ; et al. | 2005-04-14 |
| Azabicyclic ether derivatives and their use as therapeutic agents Grant 6,727,249 - Curtis , et al. April 27, 2 | 2004-04-27 |
| Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa .alpha.5 receptors Grant 6,613,766 - Curtis , et al. September 2, 2 | 2003-09-02 |
| Use of NK-1 receptor antagonists for treating major depressive disorders Grant 6,613,765 - Baker , et al. September 2, 2 | 2003-09-02 |
| Amidine derivatives as selective antagonists of ndma receptors App 20030119871 - Curtis, Neil Roy ; et al. | 2003-06-26 |
| Azabicyclic ether derivatives and their use as therapeutic agents App 20020193402 - Curtis, Neil Roy ; et al. | 2002-12-19 |
| Spiro-azacyclic derivatives and their use as therapeutic agents Grant 6,172,077 - Curtis , et al. January 9, 2 | 2001-01-09 |
| Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety Grant 6,114,315 - Baker , et al. September 5, 2 | 2000-09-05 |
| Spiro-piperidine derivatives and their use as therapeutic agents Grant 6,071,928 - Curtis , et al. June 6, 2 | 2000-06-06 |
| Spiro-piperidine derivatives and their use as therapeutic agents Grant 6,071,927 - Baker , et al. June 6, 2 | 2000-06-06 |
| Pyrrolo-pyridine derivatives Grant 5,712,285 - Curtis , et al. January 27, 1 | 1998-01-27 |
| Pyrrolo-pyridine derivatives Grant 5,700,809 - Leeson , et al. December 23, 1 | 1997-12-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 